Old Web
English
Sign In
Acemap
>
authorDetail
>
J A G Lopez
J A G Lopez
Amgen
Internal medicine
Medicine
Cardiology
Diabetes mellitus
Evolocumab
5
Papers
0
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Achievement of ESC/EAS lipid treatment goals with evolocumab in patients with type 2 diabetes: analyses of the BANTING and BERSON trials
2020
European Heart Journal
A.J Lorenzatti
J Chen
Maria Laura Monsalvo
H Wang
J A G Lopez
Robert S. Rosenson
Show All
Source
Cite
Save
Citations (0)
P5322Oxidized phospholipids on apolipoprotein B-100 among black US adults with and without PCSK9 loss-of-function variants
2019
European Heart Journal
Matthew T. Mefford
Santica M. Marcovina
Vera Bittner
Mary Cushman
Todd M. Brown
Michael E. Farkouh
Sotirios Tsimikas
Keri L. Monda
J A G Lopez
Paul Muntner
Robert S. Rosenson
Show All
Source
Cite
Save
Citations (0)
P6192Effects of evolocumab on LDL-C by race and ethnicity: an analysis of double-blind and open-label extension studies
2019
European Heart Journal
Carlos J. Rodriguez
Martha L. Daviglus
J A G Lopez
Y. Wu
Maria Laura Monsalvo
Keith C. Ferdinand
Show All
Source
Cite
Save
Citations (0)
P5326Effect of evolocumab on lipoprotein(a) levels: results across 15 studies
2019
European Heart Journal
Peter P. Toth
Steven R. Jones
Maria Laura Monsalvo
M Elliott-Davey
J A G Lopez
Maciej Banach
Show All
Source
Cite
Save
Citations (0)
P290Assessment of cardiovascular disease risk using different thresholds to define high risk on the pooled cohort equations
2018
European Heart Journal
Rikki M. Tanner
Robert S. Rosenson
Lisandro D. Colantonio
Luqin Deng
Katherine Mues
Keri L. Monda
J A G Lopez
Paul Muntner
Show All
Source
Cite
Save
Citations (0)
1